Work

Abstract C066: Matrix-M adjuvant – A promising adjuvant for preventative and therapeutic cancer vaccines development

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-c066

Authors: Berit Carow, Linda Stertman, Jonathan Fix, Sarah Sellers, Raj Kalkeri, Cecilia Carnrot, Joyce S. Plested, Robert Walker, Ruxandra Draghia-Akli

Institutions: Novavax (Sweden), Novavax (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130342729

Cites:

Cited by:

Related to: